Tag: Alzheimer’s drug
New Title: FDA Advisory Panel Approves Experimental Alzheimer’s Drug: Promising Progress Ahead
An experimental Alzheimer’s drug called donanemab received approval from a U.S. Food and Drug Administration advisory panel. The drug is intended to treat early symptoms of Alzheimer’s disease, such as mild cognitive impairment and...
Expert Panel Endorses FDA Approval of New Alzheimer’s Drug New Alzheimer’s Drug Receives Expert Panel...
An expert panel has given their endorsement to the FDA approval of a new drug for Alzheimer's disease. The drug, called donanemab and manufactured by Eli Lilly, was found to have modest benefits that...